Related Experiment Video
Updated: Jun 4, 2025
Fabrication of Extracellular Matrix-derived Foams and Microcarriers as Tissue-specific Cell Culture and Delivery Platforms
Published on: April 11, 2017
Innovative approaches to tissue engineering: Utilizing decellularized extracellular matrix hydrogels for mesenchymal
Fatemeh Soltanmohammadi1, Adel Mahmoudi Gharehbaba1, Effat Alizadeh2
1Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Pharmaceutics, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
Decellularized extracellular matrix (dECM) hydrogels protect mesenchymal stem cells (MSCs) during systemic delivery, improving tissue regeneration. These natural hydrogels enhance MSC survival and integration, overcoming limitations of traditional methods.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Stem Cell Biology
Background:
- Systemic delivery of mesenchymal stem cells (MSCs) shows promise for tissue regeneration.
- Current MSC delivery methods face challenges like poor cell survival and integration.
- Innovative carriers are needed to enhance MSC therapeutic efficacy.
Purpose of the Study:
- To review the properties and applications of decellularized extracellular matrix hydrogels (dECMHs) as carriers for MSCs.
- To explore methods of decellularization and the use of dECMHs in tissue regeneration.
- To highlight the advantages of dECMHs and hybrid hydrogels for enhanced cell therapy.
Main Methods:
- Review of existing literature on dECM hydrogels and MSC delivery.
- Analysis of decellularization techniques for ECM preparation.
- Evaluation of dECMH properties, including biocompatibility and immunogenicity.
- Investigation of dECMHs as carriers for various MSC types.
Main Results:
- dECMHs protect MSCs from hostile environments, improving survival and retention at the injection site.
- dECMHs exhibit low immunogenicity, low cytotoxicity, and high biocompatibility.
- Hybrid hydrogels incorporating dECMHs with proteins or polysaccharides offer enhanced functionalities.
- dECMHs address limitations of conventional hydrogels, boosting cell therapy efficacy.
Conclusions:
- Decellularized extracellular matrix hydrogels represent a significant advancement for systemic MSC delivery in tissue regeneration.
- dECMHs offer a biocompatible and effective platform for enhancing MSC survival and therapeutic outcomes.
- The use of dECMHs and hybrid formulations paves the way for future innovations in regenerative medicine.
